Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SIBN - SI-BONE, Inc.


IEX Last Trade
13.27
-2.400   -18.086%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:15:42 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%

$15.67
-2.40
-15.32%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
15%
Profitability 0%
Dept financing 12%
Liquidity 75%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
0.15%
1 Month
4.90%
3 Months
-5.15%
6 Months
10.49%
1 Year
-36.87%
2 Year
12.27%
Key data
Stock price
$13.27
P/E Ratio 
-16.96
DAY RANGE
$13.30 - $15.67
EPS 
-$1.00
52 WEEK RANGE
$12.11 - $21.64
52 WEEK CHANGE
-$37.93
MARKET CAP 
692.957 M
YIELD 
N/A
SHARES OUTSTANDING 
41.694 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
1.10
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$318,812
AVERAGE 30 VOLUME 
$278,259
Company detail
CEO: Laura A. Francis
Region: US
Website: si-bone.com
Employees: 350
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

SI-BONE, Inc. develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy. The company offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures.

Recent news